TERN

5.86

3.14% -0.19

Dopo l'orario di chiusura: 5.80 -0.06 -1.02%

Terns Pharmaceuticals Inc (TERN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$6.05

Aprire:

$5.9

Volume 24 ore:

4.02M

Relative Volume:

2.64

Capitalizzazione di mercato:

$497.74M

Reddito:

Utile/perdita netta:

$-95.90M

Rapporto P/E:

-4.5426

EPS:

-1.29

Flusso di cassa netto:

$-79.09M

1 W Prestazione:

-12.93%

1M Prestazione:

+4.64%

6M Prestazione:

-16.05%

1 anno Prestazione:

-6.84%

Intervallo 1D:

$5.785

$6.13

Intervallo di 1 settimana:

$5.46

$7.14

Portata 52W:

$4.32

$11.40

Terns Pharmaceuticals Inc Stock (TERN) Company Profile

Nome

Terns Pharmaceuticals Inc

Settore

Healthcare (1176)

Industria

Biotechnology (673)

Telefono

650-525-5535 EXT.101

Indirizzo

1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY

Dipendente

Cinguettio

Prossima data di guadagno

2024-11-12

Ultimi documenti SEC

TERN's Discussions on Twitter

Confronta TERN con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
TERN Terns Pharmaceuticals Inc	5.86	497.74M	0	-95.90M	-79.09M	-1.32
VRTX Vertex Pharmaceuticals Inc	397.27	102.31B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	701.85	77.13B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	623.82	37.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	245.44	31.66B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	113.08	27.11B	3.30B	-501.07M	1.03B	-2.1146

Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-10-31	Iniziato	Oppenheimer	Outperform
2023-06-22	Iniziato	Mizuho	Buy
2023-06-07	Iniziato	Jefferies	Buy
2023-05-31	Iniziato	ROTH MKM	Buy
2023-05-08	Iniziato	BMO Capital Markets	Outperform
2023-02-14	Iniziato	JMP Securities	Mkt Outperform
2023-02-07	Iniziato	UBS	Buy
2022-09-12	Iniziato	H.C. Wainwright	Neutral
2021-09-14	Ripresa	Goldman	Buy
2021-03-02	Iniziato	Cowen	Outperform
2021-03-02	Iniziato	Goldman	Buy
2021-03-02	Iniziato	JP Morgan	Overweight

Mostra tutto

Terns Pharmaceuticals Inc Borsa (TERN) Ultime notizie

Dec 18, 2024

Terns Pharmaceuticals (NASDAQ:TERN) Trading Down 4.7%Should You Sell? - MarketBeat

Dec 18, 2024

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Shares Bought by Charles Schwab Investment Management Inc. - Defense World

Dec 18, 2024

Dec 17, 2024

Terns Pharmaceuticals' SWOT analysis: promising pipeline drives stock potential - Investing.com

Dec 17, 2024

Dec 16, 2024

Is Terns Pharmaceuticals, Inc. (TERN) the Best Weight Loss Stock to Buy Now According to Hedge Funds? - Insider Monkey

Dec 16, 2024

Dec 12, 2024

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Stake Reduced by Fmr LLC - MarketBeat

Dec 12, 2024

Dec 11, 2024

Insider Spends US$110k Buying More Shares In Terns Pharmaceuticals - Simply Wall St

Dec 11, 2024

Terns Pharmaceuticals CEO & Director Acquires 423% More Stock - Yahoo Finance

Dec 11, 2024

Terns Pharmaceuticals (NASDAQ:TERN) Shares Gap Up Following Insider Buying Activity - Defense World

Dec 11, 2024

Dec 10, 2024

Terns pharmaceuticals CEO Amy Burroughs acquires $110,467 in stock - Investing.com India

Dec 10, 2024

Dec 09, 2024

Terns pharmaceuticals CEO Amy Burroughs acquires $110,467 in stock By Investing.com - Investing.com Canada

Dec 09, 2024

Dec 08, 2024

17,369 Shares in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Bought by Intech Investment Management LLC - Defense World

Dec 08, 2024

Dec 06, 2024

Terns Pharmaceuticals' SWOT analysis: stock poised for growth amid clinical milestones By Investing.com - Investing.com South Africa

Dec 06, 2024

Dec 05, 2024

Terns Pharmaceuticals' SWOT analysis: stock poised for growth amid clinical milestones - Investing.com

Dec 05, 2024

Terns Pharma broadens beyond obesity drugs with upbeat data in leukemia trial - MSN

Dec 05, 2024

Walleye Capital LLC Takes $1.55 Million Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - MarketBeat

Dec 05, 2024

Dec 04, 2024

Terns’s stock soars as analysts cheer leukemia data — and predict more gains - MSN

Dec 04, 2024

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Shares Acquired by Parkman Healthcare Partners LLC - MarketBeat

Dec 04, 2024

Cinctive Capital Management LP Buys Shares of 168,564 Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - MarketBeat

Dec 04, 2024

Terns reports positive early results in CML drug trial By Investing.com - Investing.com Nigeria

Dec 04, 2024

Dec 03, 2024

U.S. STOCKS BlackRock, Terns Pharma, PSQ Holdings - XM

Dec 03, 2024

Terns Pharmaceuticals Reports Inducement Grant to New Employee under Nasdaq Listing Rule 5635(4) - Marketscreener.com

Dec 03, 2024

Terns reports positive early results in CML drug trial - Investing.com

Dec 03, 2024

Terns Pharmaceuticals Announces Positive Early Data from - GlobeNewswire

Dec 03, 2024

Terns Pharma's CML Drug Shows 50% Response Rate in Phase 1 Trial, Strong Safety Profile - StockTitan

Dec 03, 2024

Terns Pharmaceuticals Announces Positive Early Data from Phase 1 CARDINAL Trial of TERN-701 for Chronic Myeloid Leukemia - The Manila Times

Dec 03, 2024

Dec 02, 2024

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times

Dec 02, 2024

Quantbot Technologies LP Has $1.01 Million Stock Holdings in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - MarketBeat

Dec 02, 2024

Comparing Enliven Therapeutics (NASDAQ:ELVN) & Terns Pharmaceuticals (NASDAQ:TERN) - Defense World

Dec 02, 2024

Dec 01, 2024

Bellevue Group AG Takes $8.69 Million Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - MarketBeat

Dec 01, 2024

Nov 28, 2024

Acuta Capital Partners LLC Boosts Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - MarketBeat

Nov 28, 2024

Analysts Set Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Price Target at $27.25 - Defense World

Nov 28, 2024

Nov 27, 2024

Terns Pharmaceuticals (TERN) Stock Surges Over 5% Amid Biotech S - GuruFocus.com

Nov 27, 2024

Nov 26, 2024

Companies To Watch: Terns Pharmaceuticals - Life Science Leader Magazine

Nov 26, 2024

Nov 25, 2024

Terns Pharmaceuticals' SWOT analysis: stock poised for key data readouts By Investing.com - Investing.com Canada

Nov 25, 2024

Terns Pharmaceuticals' SWOT analysis: stock poised for key data readouts - Investing.com

Nov 25, 2024

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Nov 25, 2024

Nov 22, 2024

Telemark Asset Management LLC Acquires Shares of 300,000 Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - MarketBeat

Nov 22, 2024

Non-alcoholic Steatohepatitis (NASH) Treatment Market 2032: Clinical Trials, Medication, EMA, PDMA, FDA Approvals, Epidemiology, Therapies, Companies by DelveInsight - The Globe and Mail

Nov 22, 2024

Nov 21, 2024

104,535 Shares in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Purchased by Quest Partners LLC - MarketBeat

Nov 21, 2024

Nov 20, 2024

Terns Pharmaceuticals (TERN) Stock Drops Over 5% Amidst Mixed In - GuruFocus.com

Nov 20, 2024

Nov 19, 2024

Top 3 Health Care Stocks You'll Regret Missing In Q4Amarin Corp (NASDAQ:AMRN) - Benzinga

Nov 19, 2024

Nov 18, 2024

Terns Pharmaceuticals appoints new board member - Investing.com

Nov 18, 2024

Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors - GlobeNewswire

Nov 18, 2024

Terns Pharmaceuticals, Inc. Announces Board Changes - Marketscreener.com

Nov 18, 2024

Nov 16, 2024